Insider · CIK 0001524314

Cohen Chad M

Reports to the SEC for 6 companies · WEST HOLLYWOOD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001524314

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	GRNDGrindr Inc.A Award	Director	AAward	+4,049 sh	—	—	28,596
2026-06-02	GRNDGrindr Inc.A Award	Director	AAward	+13.6K sh	—	—	24,547
2025-11-03	GRNDGrindr Inc.A Award	Director	AAward	+221 sh	—	—	10,954
2025-07-30	GRNDGrindr Inc.A Award	Director	AAward	+9,336 sh	—	—	10,733
2025-06-03	GRNDGrindr Inc.A Award	Director	AAward	−1,397 sh	—	—	1,397
2025-04-30	Vacasa, Inc.Vacasa Holdings UnitsC Conversion	Director	CConversion	−8,158 sh	—	—	0
2025-04-30	Vacasa, Inc.Vacasa Employee Holdings LLC InterestsC Conversion	Director	CConversion	−8,158 sh	—	—	0
2025-04-30	Vacasa, Inc.C Conversion	Director	CConversion	+8,158 sh	—	—	38,538
2025-04-30	Vacasa, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−38.5K sh	—	—	0
2025-04-30	Vacasa, Inc.Vacasa Holdings UnitsC Conversion	Director	CConversion	+8,158 sh	—	—	8,158
2024-07-30	GRNDGrindr Inc.A Award	Director	AAward	+9,336 sh	—	—	10,733
2024-05-21	Vacasa, Inc.A Award	Director	AAward	+20.1K sh	—	—	30,380
2023-05-23	Vacasa, Inc.A Award	Director	AAward	+171K sh	—	—	204,939
2022-05-24	Vacasa, Inc.A Award	Director	AAward	+34K sh	—	—	33,999
2021-12-22	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$7.27	+$72.7K	31,604
2021-12-22	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−10K sh	$30.00	−$300K	21,604
2021-12-22	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	80,000
2021-11-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$33.93	−$170K	21,604
2021-11-10	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	90,000
2021-11-10	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$7.27	+$36.4K	26,604
2021-11-09	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$7.27	+$36.4K	26,604
2021-11-09	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$36.03	−$180K	21,604
2021-11-09	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	95,000
2021-10-06	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$32.30	−$162K	21,604
2021-10-06	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$7.27	+$36.4K	26,604
2021-10-06	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	100,000
2021-10-05	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$7.27	+$36.4K	26,604
2021-10-05	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	105,000
2021-10-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$32.51	−$163K	21,604
2021-09-08	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$7.27	+$36.4K	26,604
2021-09-08	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$39.01	−$195K	21,604
2021-09-08	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	110,000
2021-09-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−9,375 sh	$39.71	−$372K	21,604
2021-09-07	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+9,375 sh	$6.55	+$61.4K	30,979
2021-09-07	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−9,375 sh	—	—	65,625
2021-08-11	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$6.55	+$65.5K	31,604
2021-08-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−8,738 sh	$33.48	−$293K	22,866
2021-08-11	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	75,000
2021-08-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−1,262 sh	$34.47	−$43.5K	21,604
2021-08-10	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$6.55	+$32.8K	26,604
2021-08-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−5,000 sh	$35.00	−$175K	21,604
2021-08-10	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	85,000
2021-07-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−3,514 sh	$39.20	−$138K	21,604
2021-07-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−6,486 sh	$38.17	−$248K	25,118
2021-07-07	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$6.55	+$65.5K	31,604
2021-07-07	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	90,000
2021-07-06	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	100,000
2021-07-06	ADPTAdaptive Biotechnologies CorpS Sale	Chief Financial Officer	SSale	−10K sh	$38.83	−$388K	21,604
2021-07-06	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$6.55	+$65.5K	31,604
2021-06-09	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	110,000

Recent filings

Accepted (ET)
Jun 44
Cohen Chad M0001524314-26-000001
SEC(opens sec.gov)
Nov 54
Cohen Chad M0001524314-25-000004
SEC(opens sec.gov)
Aug 224/A
Cohen Chad M0001415889-25-022836
SEC(opens sec.gov)
Aug 14
Cohen Chad M0001415889-25-020856
SEC(opens sec.gov)
Jun 54
Cohen Chad M0001415889-25-015819
SEC(opens sec.gov)
May 14
Cohen Chad M0001140361-25-016925
SEC(opens sec.gov)
May 234
Cohen Chad M0001874944-24-000062
SEC(opens sec.gov)
May 244
Cohen Chad M0001874944-23-000053
SEC(opens sec.gov)
May 254
Cohen Chad M0001874944-22-000028
SEC(opens sec.gov)
Dec 234
Cohen Chad M0001209191-21-071193
SEC(opens sec.gov)
Nov 124
Cohen Chad M0001209191-21-064253
SEC(opens sec.gov)

Companies

Address

C/O GRINDR INC. 750 N. SAN VICENTE BLVD. STE RE1400

WEST HOLLYWOOD, CA, 90069